- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Simulation-driven design of stabilized SARS-CoV-2 spike S2 immunogens ; volume:15 ; number:1 ; day:27 ; month:8 ; year:2024 ; pages:1-15 ; date:12.2024
Nature Communications ; 15, Heft 1 (27.8.2024), 1-15, 12.2024
- Creator
-
Nuqui, Xandra
Casalino, Lorenzo
Zhou, Ling
Shehata, Mohamed
Wang, Albert
Tse, Alexandra L.
Ojha, Anupam A.
Kearns, Fiona L.
Rosenfeld, Mia A.
Miller, Emily Happy
Acreman, Cory M.
Ahn, Surl-Hee
Chandran, Kartik
McLellan, Jason S.
Amaro, Rommie E.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-024-50976-9
- URN
-
urn:nbn:de:101:1-2411130739123.574169804339
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Nuqui, Xandra
- Casalino, Lorenzo
- Zhou, Ling
- Shehata, Mohamed
- Wang, Albert
- Tse, Alexandra L.
- Ojha, Anupam A.
- Kearns, Fiona L.
- Rosenfeld, Mia A.
- Miller, Emily Happy
- Acreman, Cory M.
- Ahn, Surl-Hee
- Chandran, Kartik
- McLellan, Jason S.
- Amaro, Rommie E.
- SpringerLink (Online service)
Other Objects (12)
Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge
Potent neutralization of SARS-CoV-2 variants by RBD nanoparticle and prefusion-stabilized spike immunogens
Stabilizing the closed SARS-CoV-2 spike trimer
An alphavirus replicon particle delivering prefusion-stabilized spike protein provides potent immunoprotection against SARS-CoV-2 Omicron variant
SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity
Computational epitope map of SARS-CoV-2 spike protein
Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions
MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans
A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein
Monoclonal antibodies against S2 subunit of spike protein exhibit broad reactivity toward SARS-CoV-2 variants
Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection
A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike
Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge
Potent neutralization of SARS-CoV-2 variants by RBD nanoparticle and prefusion-stabilized spike immunogens
Stabilizing the closed SARS-CoV-2 spike trimer
An alphavirus replicon particle delivering prefusion-stabilized spike protein provides potent immunoprotection against SARS-CoV-2 Omicron variant
SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity
Computational epitope map of SARS-CoV-2 spike protein
Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions
MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans
A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein
Monoclonal antibodies against S2 subunit of spike protein exhibit broad reactivity toward SARS-CoV-2 variants
Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection
A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike
Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge
Potent neutralization of SARS-CoV-2 variants by RBD nanoparticle and prefusion-stabilized spike immunogens
Stabilizing the closed SARS-CoV-2 spike trimer
An alphavirus replicon particle delivering prefusion-stabilized spike protein provides potent immunoprotection against SARS-CoV-2 Omicron variant
SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity
Computational epitope map of SARS-CoV-2 spike protein
Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions
MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans
A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein
Monoclonal antibodies against S2 subunit of spike protein exhibit broad reactivity toward SARS-CoV-2 variants
Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection